Home > GBL & 1,4-BD: Assessment of risk to the individual and communities in the UK.

Advisory Council on the Misuse of Drugs. (2008) GBL & 1,4-BD: Assessment of risk to the individual and communities in the UK. London: Home Office.

[img]
Preview
PDF (Gamma-butyrolactone (GBL) report) - Published Version
240kB

Gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD) are precursor chemicals that are rapidly converted (half-life approximately 1min) to the intoxicant gamma-hydroxybutyrate (GHB) when ingested into the human body.

GHB occurs naturally in small amounts in the brain, and is recognised by specific receptors. It may be an inhibitory neuromodulator, involved among other things in the control of glucose metabolism, oxygen consumption and temperature regulation.


Item Type
Report
Publication Type
International, Report
Drug Type
CNS depressants / Sedatives, New psychoactive substance, Prescription/Over the counter
Intervention Type
Harm reduction
Date
2008
Pages
44 p.
Publisher
Home Office
Corporate Creators
Advisory Council on the Misuse of Drugs
Place of Publication
London
EndNote
Accession Number
HRB (Electronic Only)
Related (external) link

Repository Staff Only: item control page